The EZ-Blocker is indicated for use to intubate the patient's bronchi in order to differentially isolate the left or right lung for procedures which require one-lung ventilation, lung separation.
Device Story
EZ-Blocker is a double-lumen endobronchial tube; features Y-shaped distal end with symmetrical, color-coded (blue/yellow) extensions for main stem bronchi intubation. Device includes adapter for ventilator connection. Operation: physician inserts device into bronchi; inflates low-pressure, high-volume cuffs in main stem branches of non-ventilated lung to achieve isolation. Enables one-lung ventilation during surgical procedures. Benefits: facilitates lung separation and differential ventilation.
Clinical Evidence
Bench testing only. No clinical data provided. Testing included ISO 10993-1 biocompatibility (cytotoxicity, sensitization, irritation), balloon verification (resting diameter, leakage, collapse, burst), and gas barrier retention testing (up to 6 hours). Assembly validated for function and bond strength.
Technological Characteristics
Double-lumen endobronchial tube; materials: silicone and polyurethane. Features Y-shaped distal tip with color-coded extensions. Low-pressure, high-volume balloons. Includes ventilator adapter. Dimensions: 69 cm tubing, 75 cm overall length. Sterilization method not specified. Standalone mechanical device; no software or electronic components.
Indications for Use
Indicated for patients requiring one-lung isolation for procedures necessitating lung separation. Used in hospital OR and ICU settings.
Regulatory Classification
Identification
A tracheal/bronchial differential ventilation tube is a device used to isolate the left or the right lung of a patient for anesthesia or pulmonary function testing.
K021920 — 7.0 FR. ENDOBRONCHIAL BLOCKER · Cook, Inc. · Aug 14, 2002
Submission Summary (Full Text)
{0}------------------------------------------------
121462
## 510(k) Summary
- Submitted by:
EZ-Blocker B.V. Delftechpark 26 Delft 2628 XH The Netherlands
- Contact Person: Lewis Ward L.W. Ward and Associates, Inc. 4655 Kirkwood Court Boulder, CO 80301 303-530-3279
9-14-2012 Date Prepared:
Product: EZ-Blocker
- Classification Name: Tracheal/bronchial differential ventilation tube, Product Code CBI Regulation Number 868.5740
- Intended Use: The EZ-Blocker is indicated for use to intubate the patient's bronchi in order to differentially isolate the left or right lung for procedures which require one-lung ventilation, lung separation.
# Technological Characteristics:
The EZ-Blocker is a double lumen endobronchial tube made of polymer materials and inks. The distal part of the tube ends in a "y" shape with distal extensions for each branch of the lung. The extensions are symmetrical and colored differently (blue and yellow) for identification purposes. The device is supplied with an adapter for connection to a ventilator device. The symmetrical design facilitates introduction and positioning of the device in both main stem bronchi. When properly positioned, the cuff in the main stem branches of the non-ventilated lung can be inflated and lung isolation is achieved.
8 2012
{1}------------------------------------------------
# Substantial Equivalence:
.
| Feature | Cook Inc. Endobronchial<br>Blocker, K021920 | EZ-Blocker®<br>This submission |
|---------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indication for Use | The 7.0 Fr. Endobronchial<br>Blocker is intended for use to<br>differentially intubate a patient's<br>bronchus in order to isolate the<br>left or right lung for procedures<br>which require one-lung<br>ventilation. | The EZ-Blocker is indicated for<br>use to intubate the patient's<br>bronchi in order to differentially<br>isolate the left or right lung for<br>procedures which require one-<br>lung ventilation, lung separation. |
| Company | Cook Inc. | EZ-Blocker B.V. |
| Distal Tip | Single | Double |
| Average Inflation<br>Volume Range | 2.0 cc – 12.0 cc | Max 12.0 cc (recommended) |
| Balloon | Low-pressure, high-volume<br>Spherical or Elliptical | Low-pressure, high-volume |
| Lengths | 50, 65, 78 cm | Tubing 69 cm<br>Overall length 75 cm |
| Materials | Unknown | Silicone, Polyurethane |
| Biocompatibility | Performed but not specified | Cytotoxicity, Sensitization,<br>Irritation - PASS |
| Testing for verifying<br>characteristics of the<br>cuff | - Analysis of cuff pressure at<br>various inflation volumes<br>- Analysis of balloon cuff<br>inflation retention | CMI performed Balloon<br>Verification Test No. ECO-<br>00967-002 consisting of:<br>checking of resting diameter,<br>leakage, collapsing of balloon,<br>and burst test. |
| Gas Barrier property | Unknown | CMI has verified by testing that<br>the balloon retains gas without<br>significant changes in volume up<br>to 6 hours after inflation. |
| Packaging | Pouch | Pouch |
| Shelf Life | Unknown | 2 years expiration dated |
.
{2}------------------------------------------------
Test Data:
The EZ-Blocker has been tested and confirmed safe under ISO 10993-1 biocompatibility requirements. The assembly is validated for function, leakage, and bond strength. The device is confirmed safe and effective as a device used in standard medical practice.
The EZ-Blocker is substantially equivalent to the Cook Inc. Endobronchial Blocker K021920 based on the performance data.
{3}------------------------------------------------
# DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a stylized eagle emblem. The eagle is depicted with its wings spread, symbolizing protection and service. The overall design is simple and professional, reflecting the department's role in public health and human services.
#### Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
EZ-Blocker B.V. C/O Mr. Lewis Ward President L.W. Ward And Associates, Incorporated 4655 Kirkwood Court Boulder, Colorado 80301
Re: K121462
Trade/Device Name: EZ-Blocker® Regulation Number: 21 CFR 868.5740 Regulation Name: Tracheal/Bronchial Differential Ventilation Tube Regulatory Class: II Product Code: CBI Dated: September 14, 2012 Received: September 17, 2012
Dear Mr. Ward:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{4}------------------------------------------------
#### Page 2- Mr. Ward
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
hh for
Anthony D. Watson, B.S., M.S., M.B.A. Director
Division of Anesthesiology, General Hospital, Infection Control and Dental Devices
Office of Device Evaluation Center for Devices and
Radiological Health
Enclosure
{5}------------------------------------------------
### INDICATIONS FOR USE
510(k) Number (if known):
Device Name: EZ-Blocker®
Indications for Use:
The EZ-Blocker is indicated for use to intubate the patient's bronchi in order to differentially isolate the left or right lung for procedures which require one-lung ventilation, lung separation. Patient population: Patients requiring one lung isolation. Environment of use: Hospitals - OR and ICU.
AND/OR Prescription Use X (Part 21 CFR 801 Subpart D)
Over-the-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) 1
Concurrence of CDRH, Office of Device Evaluation (ODE)
y. Schulten
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: k121467
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.